<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="8" family="AkzidenzGroteskBE-Md,Bold" color="#000000"/>
	<fontspec id="font1" size="8" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font2" size="8" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font3" size="7" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font4" size="9" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font5" size="11" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font6" size="8" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font7" size="8" family="AkzidenzGroteskBE" color="#ffffff"/>
<text top="42" left="56" width="181" height="7" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">Breast Cancer Research Vol 8 No 5    Preda et al.<b>Breast Cancer Research</b></text>
<text top="758" left="56" width="40" height="7" font="font1" id="p1_t2" reading_order_no="78" segment_no="13" tag_type="text">Page 6 of 9</text>
<text top="768" left="56" width="120" height="6" font="font3" id="p1_t3" reading_order_no="79" segment_no="14" tag_type="text">(page number not for citation purposes)<i>et al.</i></text>
<text top="261" left="56" width="240" height="9" font="font4" id="p1_t4" reading_order_no="5" segment_no="3" tag_type="text">Six true-positive cases were identified, one case graded as</text>
<text top="273" left="56" width="240" height="9" font="font4" id="p1_t5" reading_order_no="6" segment_no="3" tag_type="text">Fischer 4, two cases graded as Fischer 5, two cases graded<i>(page number not for citation purposes)</i></text>
<text top="285" left="56" width="240" height="9" font="font4" id="p1_t6" reading_order_no="7" segment_no="3" tag_type="text">as Fischer 6, and one case graded as Fischer 8. Among these</text>
<text top="297" left="56" width="240" height="9" font="font4" id="p1_t7" reading_order_no="8" segment_no="3" tag_type="text">patients, 3/6 had no malignancy on the surgical scar: one of</text>
<text top="308" left="56" width="240" height="9" font="font4" id="p1_t8" reading_order_no="9" segment_no="3" tag_type="text">them underwent a controlateral quadrantectomy; the remain-</text>
<text top="320" left="56" width="240" height="9" font="font4" id="p1_t9" reading_order_no="10" segment_no="3" tag_type="text">ing two patients, having enhancing lesions in a different quad-</text>
<text top="332" left="56" width="240" height="9" font="font4" id="p1_t10" reading_order_no="11" segment_no="3" tag_type="text">rant, underwent a total mastectomy. Three out of six patients</text>
<text top="344" left="56" width="240" height="9" font="font4" id="p1_t11" reading_order_no="12" segment_no="3" tag_type="text">had second cancer foci distant from the scar as well as on the</text>
<text top="355" left="56" width="240" height="9" font="font4" id="p1_t12" reading_order_no="13" segment_no="3" tag_type="text">scar, confirmed by histology as multifocal carcinomas: in two</text>
<text top="367" left="56" width="240" height="9" font="font4" id="p1_t13" reading_order_no="14" segment_no="3" tag_type="text">cases the enhancing lesions were on the same quadrant and</text>
<text top="379" left="56" width="241" height="9" font="font4" id="p1_t14" reading_order_no="15" segment_no="3" tag_type="text">the patients underwent a second quadrantectomy, and in one</text>
<text top="391" left="56" width="240" height="9" font="font4" id="p1_t15" reading_order_no="16" segment_no="3" tag_type="text">case the lesion was in another quadrant and the patient under-</text>
<text top="402" left="56" width="240" height="9" font="font4" id="p1_t16" reading_order_no="17" segment_no="3" tag_type="text">went a total mastectomy (Figure 4). For 3/6 true-positive</text>
<text top="414" left="56" width="240" height="9" font="font4" id="p1_t17" reading_order_no="18" segment_no="3" tag_type="text">cases, all graded as BI-RADS IV at mammography, second-</text>
<text top="426" left="56" width="240" height="9" font="font4" id="p1_t18" reading_order_no="19" segment_no="3" tag_type="text">look ultrasound examinations were performed: in all three<a href="">e 4). For 3/6 </a>true-positive</text>
<text top="438" left="56" width="240" height="9" font="font4" id="p1_t19" reading_order_no="20" segment_no="3" tag_type="text">cases the lesion was detected. Only in 1/3 had an ultrasound</text>
<text top="449" left="56" width="240" height="9" font="font4" id="p1_t20" reading_order_no="21" segment_no="3" tag_type="text">examination been performed before the MRM, and it was con-</text>
<text top="461" left="56" width="67" height="9" font="font4" id="p1_t21" reading_order_no="22" segment_no="3" tag_type="text">sidered negative.</text>
<text top="485" left="56" width="240" height="9" font="font4" id="p1_t22" reading_order_no="23" segment_no="7" tag_type="text">Two false positive-cases were detected; they were graded as</text>
<text top="496" left="56" width="240" height="9" font="font4" id="p1_t23" reading_order_no="24" segment_no="7" tag_type="text">Fischer 4, demonstrated as negative by histological findings</text>
<text top="508" left="56" width="108" height="9" font="font4" id="p1_t24" reading_order_no="25" segment_no="7" tag_type="text">and confirmed by follow-up.</text>
<text top="532" left="56" width="240" height="9" font="font4" id="p1_t25" reading_order_no="26" segment_no="8" tag_type="text">Five true-negative cases confirmed by negative findings during</text>
<text top="543" left="56" width="240" height="9" font="font4" id="p1_t26" reading_order_no="27" segment_no="8" tag_type="text">the follow-up were graded as follows: one case graded as</text>
<text top="555" left="56" width="183" height="9" font="font4" id="p1_t27" reading_order_no="28" segment_no="8" tag_type="text">Fischer 2, and four cases graded as Fischer 3.</text>
<text top="579" left="56" width="241" height="9" font="font4" id="p1_t28" reading_order_no="29" segment_no="10" tag_type="text">During the follow-up, no enhancing lesions remote from the</text>
<text top="590" left="56" width="241" height="9" font="font4" id="p1_t29" reading_order_no="30" segment_no="10" tag_type="text">scar  were  detected  in  any  of the 80 patients with negative</text>
<text top="602" left="56" width="234" height="9" font="font4" id="p1_t30" reading_order_no="31" segment_no="10" tag_type="text">MRM, thus confirming the absence of false-negative results.</text>
<text top="626" left="56" width="241" height="9" font="font4" id="p1_t31" reading_order_no="32" segment_no="11" tag_type="text">The sensitivity, specificity, negative predictive value, positive</text>
<text top="637" left="56" width="240" height="9" font="font4" id="p1_t32" reading_order_no="33" segment_no="11" tag_type="text">predictive value and accuracy of MRM for the detection of</text>
<text top="649" left="56" width="240" height="9" font="font4" id="p1_t33" reading_order_no="34" segment_no="11" tag_type="text">recurrence on the surgical scar were, respectively, 90%,</text>
<text top="661" left="56" width="240" height="9" font="font4" id="p1_t34" reading_order_no="35" segment_no="11" tag_type="text">91.6%, 98.7%, 56.3% and 91.4%. The overall sensitivity, spe-</text>
<text top="673" left="56" width="240" height="9" font="font4" id="p1_t35" reading_order_no="36" segment_no="11" tag_type="text">cificity, negative predictive value, positive predictive value and</text>
<text top="684" left="56" width="240" height="9" font="font4" id="p1_t36" reading_order_no="37" segment_no="11" tag_type="text">accuracy of MRM in the detection of breast cancer lesions</text>
<text top="696" left="56" width="240" height="9" font="font4" id="p1_t37" reading_order_no="38" segment_no="11" tag_type="text">(including areas not related to the scar) were, respectively,</text>
<text top="708" left="56" width="240" height="9" font="font4" id="p1_t38" reading_order_no="39" segment_no="11" tag_type="text">93.8% (95% confidence interval, 82–100%), 90% (95% con-</text>
<text top="720" left="56" width="213" height="9" font="font4" id="p1_t39" reading_order_no="40" segment_no="11" tag_type="text">fidence interval, 83–96%), 98.8%, 62.5% and 90.6%.</text>
<text top="261" left="315" width="57" height="10" font="font5" id="p1_t40" reading_order_no="41" segment_no="4" tag_type="title">Discussion</text>
<text top="273" left="315" width="241" height="9" font="font4" id="p1_t41" reading_order_no="42" segment_no="5" tag_type="text">The long-term survival rate among women who undergo</text>
<text top="285" left="315" width="240" height="9" font="font4" id="p1_t42" reading_order_no="43" segment_no="5" tag_type="text">breast-conserving surgery is the same as that among women<b>Discussion</b></text>
<text top="297" left="315" width="240" height="9" font="font4" id="p1_t43" reading_order_no="44" segment_no="5" tag_type="text">who undergo radical mastectomy [12]. Breast-conserving sur-</text>
<text top="308" left="315" width="240" height="9" font="font4" id="p1_t44" reading_order_no="45" segment_no="5" tag_type="text">gery is therefore currently considered the treatment of choice</text>
<text top="320" left="315" width="240" height="9" font="font4" id="p1_t45" reading_order_no="46" segment_no="5" tag_type="text">for women with relatively small breast cancers [12], and the<a href="">rgo radical mastectomy [12]. Bre</a>ast-conserving sur-</text>
<text top="332" left="315" width="240" height="9" font="font4" id="p1_t46" reading_order_no="47" segment_no="5" tag_type="text">rate of recurrence reported in these patients is about 1–2%</text>
<text top="344" left="315" width="240" height="9" font="font4" id="p1_t47" reading_order_no="48" segment_no="5" tag_type="text">per year [1,2]. Long-term survival of patients with new malig-<a href="">s [12],</a> and the</text>
<text top="355" left="315" width="240" height="9" font="font4" id="p1_t48" reading_order_no="49" segment_no="5" tag_type="text">nancy after conservative treatment improves with early detec-</text>
<text top="367" left="315" width="49" height="9" font="font4" id="p1_t49" reading_order_no="50" segment_no="5" tag_type="text">tion [10,13].<a href="">1,2]. Long-term su</a>rvival of patients with new malig-</text>
<text top="391" left="315" width="240" height="9" font="font4" id="p1_t50" reading_order_no="51" segment_no="6" tag_type="text">The diagnostic evaluation of the treated breast is unfortunately</text>
<text top="402" left="315" width="240" height="9" font="font4" id="p1_t51" reading_order_no="52" segment_no="6" tag_type="text">still a challenge because post-treatment changes of breast tis-<a href="">tion [10,13].</a></text>
<text top="414" left="315" width="240" height="9" font="font4" id="p1_t52" reading_order_no="53" segment_no="6" tag_type="text">sue can show great variability, hiding or mimicking recurrent</text>
<text top="426" left="315" width="240" height="9" font="font4" id="p1_t53" reading_order_no="54" segment_no="6" tag_type="text">lesions [3,14]. Changes following breast-conserving surgery</text>
<text top="438" left="315" width="240" height="9" font="font4" id="p1_t54" reading_order_no="55" segment_no="6" tag_type="text">can include hematoma, seroma, fat tissue necrosis, scar tissue</text>
<text top="449" left="315" width="240" height="9" font="font4" id="p1_t55" reading_order_no="56" segment_no="6" tag_type="text">development and dystrophic calcifications [15]. Changes after<a href="">lesions [3,14]. Changes </a>following breast-conserving surgery</text>
<text top="461" left="315" width="240" height="9" font="font4" id="p1_t56" reading_order_no="57" segment_no="6" tag_type="text">radiotherapy can include vascular dilatation, capillary damage,</text>
<text top="473" left="315" width="240" height="9" font="font4" id="p1_t57" reading_order_no="58" segment_no="6" tag_type="text">microcirculatory changes and edema [15,16]. The association<a href="">ions [15]</a>. Changes after</text>
<text top="485" left="315" width="241" height="9" font="font4" id="p1_t58" reading_order_no="59" segment_no="6" tag_type="text">of these changes after breast-conserving surgery and irradia-</text>
<text top="496" left="315" width="240" height="9" font="font4" id="p1_t59" reading_order_no="60" segment_no="6" tag_type="text">tion make the interpretation of clinical examination and mam-<a href="">anges and edema [15,16]. The assoc</a>iation</text>
<text top="508" left="315" width="240" height="9" font="font4" id="p1_t60" reading_order_no="61" segment_no="6" tag_type="text">mography very difficult because of focal thickening, decreased</text>
<text top="520" left="315" width="240" height="9" font="font4" id="p1_t61" reading_order_no="62" segment_no="6" tag_type="text">compressibility and increased density at the surgical site</text>
<text top="532" left="315" width="26" height="9" font="font4" id="p1_t62" reading_order_no="63" segment_no="6" tag_type="text">[3,13].</text>
<text top="555" left="315" width="240" height="9" font="font4" id="p1_t63" reading_order_no="64" segment_no="9" tag_type="text">At our institution the usual follow-up of breast cancer patients</text>
<text top="567" left="315" width="240" height="9" font="font4" id="p1_t64" reading_order_no="65" segment_no="9" tag_type="text">treated with breast-conserving surgery and irradiation is based<a href="">[3,13].</a></text>
<text top="579" left="315" width="240" height="9" font="font4" id="p1_t65" reading_order_no="66" segment_no="9" tag_type="text">on annual imaging evaluation performed with mammography,</text>
<text top="590" left="315" width="240" height="9" font="font4" id="p1_t66" reading_order_no="67" segment_no="9" tag_type="text">completed by clinical examination and/or ultrasound examina-</text>
<text top="602" left="315" width="168" height="9" font="font4" id="p1_t67" reading_order_no="68" segment_no="9" tag_type="text">tion, according to the density of the breast.</text>
<text top="626" left="315" width="240" height="9" font="font4" id="p1_t68" reading_order_no="69" segment_no="12" tag_type="text">Local recurrence is the development of a tumor in the ipsilat-</text>
<text top="637" left="315" width="241" height="9" font="font4" id="p1_t69" reading_order_no="70" segment_no="12" tag_type="text">eral (treated) breast that occurs after treatment of the initial</text>
<text top="649" left="315" width="240" height="9" font="font4" id="p1_t70" reading_order_no="71" segment_no="12" tag_type="text">breast cancer [17]. Comparison of studies relating to the</text>
<text top="661" left="315" width="240" height="9" font="font4" id="p1_t71" reading_order_no="72" segment_no="12" tag_type="text">detection of recurrence can be difficult because of differences</text>
<text top="673" left="315" width="240" height="9" font="font4" id="p1_t72" reading_order_no="73" segment_no="12" tag_type="text">in the definitions of local recurrence [17]. Mammography has<a href="">r [17].</a> Comparison of studies relating to the</text>
<text top="684" left="315" width="240" height="9" font="font4" id="p1_t73" reading_order_no="74" segment_no="12" tag_type="text">limited sensitivity in these lesions [8,18], because of an</text>
<text top="696" left="315" width="240" height="9" font="font4" id="p1_t74" reading_order_no="75" segment_no="12" tag_type="text">insufficient morphological distinction between therapy-<a href="">17].</a> Mammography has</text>
<text top="708" left="315" width="240" height="9" font="font4" id="p1_t75" reading_order_no="76" segment_no="12" tag_type="text">induced edema and lymphangiosis carcinomatosa or between<a href=""> lesions [8,18], be</a>cause of an</text>
<text top="720" left="315" width="240" height="9" font="font4" id="p1_t76" reading_order_no="77" segment_no="12" tag_type="text">radially striated scar tissue and tumor recurrence [15]. This</text>
<text top="85" left="56" width="31" height="7" font="font6" id="p1_t77" reading_order_no="1" segment_no="1" tag_type="title">Figure 4</text>
<text top="227" left="56" width="299" height="7" font="font7" id="p1_t78" reading_order_no="2" segment_no="2" tag_type="text">Magnetic resonance mammography 2 years after therapies for invasive ductal carcinoma<a href="">e [15]. Th</a>is</text>
<text top="227" left="56" width="493" height="7" font="font0" id="p1_t79" reading_order_no="3" segment_no="2" tag_type="text">Magnetic resonance mammography 2 years after therapies for invasive ductal carcinoma. This shows two lesions (arrows) (Breast Imaging<b>Figure 4</b></text>
<text top="236" left="56" width="228" height="7" font="font1" id="p1_t80" reading_order_no="4" segment_no="2" tag_type="text">Reporting and Data System IV, V), reported by biopsy as malignant.</text>
</page>
</pdf2xml>
